[
Children enrolled in Pennsylvania's Children's Health Insurance Program (CHIP) should receive two lead blood tests for the detection of elevated blood lead levels (EBLL) before their second birthday. The first test should be done between ages 9 to 12 months; the second test prior to or no later than 24 months; and thereafter based on risk.
Recognizing your recommendation has tremendous influence on the parents/guardians of your pediatric patients and their decision to seek lead testing and screening information for their children, we are requesting your participation in ensuring all CHIP members receive lead testing before their second birthday. It is also important to note that all CHIP members, regardless of risk level, should be tested for EBLLs. Performing a risk-assessment questionnaire instead of a blood lead test does not meet this requirement.
The difference between lead testing and lead screening
A lead test is one or more capillary or venous blood test administered on or before a child's second birthday and thereafter based on risk. Lead screening is described as an assessment or questionnaire regarding a child's health or living environment. The Pennsylvania Insurance Department's requirement for CHIP members is for a lead test and not just lead screening. Children should be screened by performing a risk assessment starting at 6 months, again at 9 and 18 months, and then annually from ages 3 to 6, with testing as appropriate.
Identifying CHIP members
Independence ID cards for CHIP members include the identifying words "PA Kids" written on the front, as shown in the sample CHIP ID card below.
![CHIP Member ID Card]()
Resources
The following resources provide additional information regarding lead testing recommendations:
]